Regulatory tracker: Innovent's Sycume becomes China's first approved IGF-1R monoclonal antibody
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.
